Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2021 08:00 ET | Source: Kane Biotech Inc.

Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+™ Technology for Wound Care, Skin Infections and Personal Care Formulations

WINNIPEG, Manitoba, July 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has received two Decisions to Grant from the European Patent Office for patents covering its best-in-class...
July 29, 2021 06:30 ET | Source: InterDigital, Inc.

InterDigital Wins Key Patent Verdict Against Lenovo from the UK’s High Court

Patent-in-suit found to be valid, infringed and essential to the 4G LTE wireless standard by the UK’s High Court.Decision underlines the value of InterDigital’s wireless patent portfolio.Trial to...
July 27, 2021 08:08 ET | Source: Silo Pharma, Inc.

Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent

Central Nervous System Homing Peptide under development to deliver Psychedelics including Psilocybin Englewood Cliffs NJ, July 27, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB:SILO), a...
July 27, 2021 08:00 ET | Source: electroCore, Inc.

electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones

ROCKAWAY, NJ, July 27, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the United States Patent and Trademark...
July 26, 2021 08:00 ET | Source: FuelPositive Corp.

FuelPositive Hires Core NH3 Technology Patent Co-Inventor Dr. Ghassan Chehade to Lead Prototype Manufacturing

TORONTO, July 26, 2021 (GLOBE NEWSWIRE) -- FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) (“FuelPositive” or the “Company”) has hired engineer Dr. Ghassan Chehade, one of the co-inventors...
July 22, 2021 08:00 ET | Source: Recce Pharmaceuticals

Recce Pharmaceuticals Announces Anti-Viral Patent Granted in USA for RECCE® Anti-Infectives

SYDNEY, Australia, July 22, 2021 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q), the Company developing new classes of synthetic anti-infectives, is pleased to announce the United...
July 21, 2021 08:00 ET | Source: PharmaTher Holdings Ltd.

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

Strengthens position to become a leader in the intradermal delivery of FDA prescription-based ketamine productsSupports commercializing novel uses and delivery methods of psychedelics TORONTO, July ...
July 21, 2021 03:00 ET | Source: Core One Labs Inc.

Core One Labs’ Akome Biotech Protects New AKO003 Ketamine-Based Breakthrough Drug Formulation For Depression Treatment

VANCOUVER, British Columbia, July 21, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL) (OTC: CLABD) (Frankfurt: LD6, WKN:A3CSSU) (the “Company”) is excited to announce that its wholly owned...
July 20, 2021 08:30 ET | Source: Zosano Pharma Corporation

Zosano Pharma Announces Issuance of U.S. Patent for Method of Rapidly Achieving Therapeutic Levels with M207 for the Acute Treatment of Migraine

FREMONT, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has been granted an additional patent...
July 20, 2021 07:30 ET | Source: SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics Announces Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Mirdametinib, Extending Patent Protection Into 2041

STAMFORD, Conn., July 20, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No....